RNA- and DNA-binding activities in hepatitis B virus capsid protein: a model for their roles in viral replication
- PMID: 1501273
- PMCID: PMC289076
- DOI: 10.1128/JVI.66.9.5232-5241.1992
RNA- and DNA-binding activities in hepatitis B virus capsid protein: a model for their roles in viral replication
Abstract
The hepatitis B virus capsid or core protein (p21.5) binds nucleic acid through a carboxy-terminal protamine region that contains nucleic acid-binding motifs organized into four repeats (I to IV). Using carboxy-terminally truncated proteins expressed in Escherichia coli, we detected both RNA- and DNA-binding activities within the repeats. RNA-binding and packaging activity, assessed by resolving purified E. coli capsids on agarose gels and disclosing their RNA content with ethidium bromide, required only the proximal repeat I (RRRDRGRS). Strikingly, a mutant in which four Arg residues replaced repeat I was competent to package RNA, demonstrating that Arg residues drive RNA binding. In contrast, probing immobilized core proteins with 32P-nucleic acid revealed an activity which (i) required more of the protamine region (repeats I and II), (ii) appeared to bind DNA better than RNA, and (iii) was apparently modulated by phosphorylation in p21.5 derived from Xenopus oocytes. Deletion analysis suggested that this activity may depend on an SPXX-type DNA-binding motif in repeat II. Similar motifs found in repeats III and IV may also function to bind DNA. On the basis of these observations, together with a reinterpretation of recent studies showing that capsid protein mutants cause defects in viral genome replication, we propose a model suggesting that hepadnavirus capsid proteins participate directly in the intracapsid reverse transcription of RNA into DNA. In this model, repeat I binds RNA whereas the distal repeats are progressively recruited to bind elongating DNA strands. The latter motifs may be required for replication to be energetically feasible.
Similar articles
-
Carboxy-terminal truncations of the HBV core protein affect capsid formation and the apparent size of encapsidated HBV RNA.Virology. 1993 Jun;194(2):597-607. doi: 10.1006/viro.1993.1299. Virology. 1993. PMID: 7684872
-
Stability governs the apparent expression of "particulate" hepatitis B e antigen by mutant hepatitis B virus core particles.Virology. 1993 Sep;196(1):70-8. doi: 10.1006/viro.1993.1455. Virology. 1993. PMID: 7689282
-
Effect of a hepatitis B virus inhibitor, NZ-4, on capsid formation.Antiviral Res. 2016 Jan;125:25-33. doi: 10.1016/j.antiviral.2015.11.004. Epub 2015 Nov 30. Antiviral Res. 2016. PMID: 26611395
-
Assembly and antigenicity of hepatitis B virus core particles.Intervirology. 1995;38(1-2):47-62. doi: 10.1159/000150414. Intervirology. 1995. PMID: 8666524 Review.
-
RNA-protein interactions in hepadnavirus reverse transcription.Front Biosci (Landmark Ed). 2009 Jan 1;14(5):1606-18. doi: 10.2741/3328. Front Biosci (Landmark Ed). 2009. PMID: 19273150 Free PMC article. Review.
Cited by
-
The inhibitory effect of the hepatitis B virus singly-spliced RNA-encoded p21.5 protein on HBV nucleocapsid formation.PLoS One. 2015 Mar 18;10(3):e0119625. doi: 10.1371/journal.pone.0119625. eCollection 2015. PLoS One. 2015. PMID: 25785443 Free PMC article.
-
C-terminal substitution of HBV core proteins with those from DHBV reveals that arginine-rich 167RRRSQSPRR175 domain is critical for HBV replication.PLoS One. 2012;7(7):e41087. doi: 10.1371/journal.pone.0041087. Epub 2012 Jul 20. PLoS One. 2012. PMID: 22911745 Free PMC article.
-
Low-level secretion of human hepatitis B virus virions caused by two independent, naturally occurring mutations (P5T and L60V) in the capsid protein.J Virol. 2000 Oct;74(19):9099-105. doi: 10.1128/jvi.74.19.9099-9105.2000. J Virol. 2000. PMID: 10982356 Free PMC article.
-
Marek's disease herpesvirus transforming protein MEQ: a c-Jun analogue with an alternative life style.Virus Genes. 2000;21(1-2):51-64. Virus Genes. 2000. PMID: 11022789 Review.
-
Revisiting Hepatitis B Virus: Challenges of Curative Therapies.J Virol. 2019 Sep 30;93(20):e01032-19. doi: 10.1128/JVI.01032-19. Print 2019 Oct 15. J Virol. 2019. PMID: 31375584 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources